Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-17

Clinical Trial Update: Novel Drug Delivery Technique Via Retroject Device [Phase 1, Phase 2]

View source ↗

Summary

The study reports completion of a Phase 1/2 trial of a novel retroject device-based drug delivery technique for glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Molly Walsh | Conditions: Glaucoma | Phase 1, Phase 2 | Status: COMPLETED